


















QIAGEN Discovery Platform brings together biomedical knowledge and AI agents into a single, cohesive ecosystem. It provides a universal semantic layer that empowers a modular system of agents all drawing from the same source of biological reality.
Move beyond pattern recognition, avoid shallow answers and reduce hallucinations with the structured causality your models need.

Understand the context that creates complex biological interactions and affects their outcomes
Explore data from published research and public databases
Anchor your LLMs in quality data, curated with human expertise and reasoning
Discover unexpected connections and create new hypotheses
Connect your existing data to our curated genes, proteins, pathways, diseases and drugs
Add new data as scientific knowledge progresses and you make more discoveries
Create profiles of diseases, phenotypes and biological processes, including associated genes and compounds
Find causally relevant genes and explore associations with similar diseases or phenotypes
QIAGEN Discovery Platform provides a single, unified source of large-scale biomedical data for mechanistic reasoning and auditable agentic workflows.
Create a custom semantic layer for your AI agents that combines your internal data and our high-quality data into biological truth.

Integrate one traceable knowledge graph into your infrastructure, reducing complexity and points of failure
Improve model confidence with mechanism-based prioritization, pathway scoring and interpretable GraphRAG
Develop scalable, auditable XAI applications based on structured biological knowledge
Create reliable insights from reliable data.




We use our leading data, advanced analytics and AI to answer your scientific questions and build custom applications.

Discover how our biomedical knowledge graph can help accelerate your data science-driven drug discovery.

See how researchers at Sanofi identified protein kinase RIPK1 as a molecular driver of ALS and used this insight to find candidate biomarkers for targeted therapies.